The future of news
Not content with merely displaying our news, computers are beginning to write it - and a story today on ResMed's interim result shows they're getting pretty good at it.
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
Browsing around for news and comment on ResMed's (ASX: RMD) (excellent) second quarter result this morning, I came across this news story on CNBC. It's short and sweet, but does the job, as they say.
The company made profit and earnings per share of blah, which beat analysts' forecasts of blah. Sales of blah also beat forecasts of blah. There's even some nice detail specific to ResMed – which was described as a 'San Diego-based company' and a 'maker of medical products for respiratory disorders' (which is as good a way of describing it as I've come up with over the years).
The article goes on to describe the share price reaction on the day and notes that it's up 33% over the past 12 months.
All good stuff and written nicely enough, so I was amazed to read at the end of the article that it had been 'generated by Automated Insights using data from Zacks Investment Research'. I've come across computer-generated news stories before, of course, but never as good as this. Without the note at the bottom I would never have known.
Just as the future looks bleak for newspapers, it's starting to look tough for generic news reporters.
Disclosure: The author owns shares in ResMed.
Call 1300 880 160
Start a chat
Schedule a call
